Give Patients the Choice to Test for DPD Deficiency Before Fluoropyrimidine Chemotherapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39626133.
- Also identified by DOI 10.1200/OP.24.00443.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients, not physicians, should decide if DPYD screening is right for them before FU/Xeloda chemotherapy.
Medical subject headings
- Dihydropyrimidine Dehydrogenase Deficiency